Genetic studies indicate that AF may be linked to specific genetic abnormalities, particularly mutations in the β-catenin gene, which disrupt the normal function of the Wnt/APC/β-catenin signaling pathway, leading to tumor formation. This evidence concerns the gene APC and neoplasm.